Showing results (1721-1730 of 2,362) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|January 1, 1985
Single-dose kinetics and bioavailability of sodium-hydrogen divalproateP Anderson, C E ElwinClinical Neuropharmacology|December 3, 2009
Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramateStephen I Deutsch, Jessica A Burket, Richard B RosseClinical Neuropharmacology|September 9, 2026
Candesartan for Migraine Prophylaxis: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsMohammed R Abdeldayem, Ahmed ElsherbeenyClinical Neuropharmacology|September 18, 2026
Zinc-associated Copper Deficiency Myelopathy: A Case ReportZachary Goodrich, Jennifer SchneiderClinical Neuropharmacology|September 18, 2026
Benzodiazepine-Sparing Alcohol Withdrawal Protocol Pilot in Postsurgical Head and Neck Cancer PatientsAnna P Shapiro-Krew, Andrew Coulter, Marilyn Davies, et al.Clinical Neuropharmacology|January 1, 1985
Qualitative assessment of Parkinson's disease: study of reliability and data reduction with an abbreviated Columbia ScaleG K Montgomery, N C Reynolds, R M WarrenClinical Neuropharmacology|August 1, 1989
Chronic diazepam treatment induces an increase in peripheral benzodiazepine binding sitesR Weizman, M GavishClinical Neuropharmacology|November 11, 2014
Dopamine agonist modifies cortical activity in Parkinson disease: a functional neuroimaging studyClaudio Lucetti, Stefano Diciotti, Filippo Baldacci, et al.Clinical Neuropharmacology|November 11, 2014
Antidepressant-emergent mood switch in Korean adolescents with mood disorderKee Jeong Park, Seunghyun Shon, Hyun-Jeong Lee, et al.Clinical Neuropharmacology|April 1, 1989
Intravenous yohimbine. Selective enhancer of norepinephrine and cortisol secretion and systolic blood pressure in humansL Grunhaus, D Tiongco, T Zelnik, et al.Pageof 237